Diagnos Inc. announce the appointment, effective November 27, 2019, of Mr. Francis Bellido to the Corporation’s board of directors. Mr. Bellido has spent his career overseeing and leading the development of several organizations in the healthcare industry. He brings sound financial management expertise, deep operating and leadership experience, and a global business perspective that he acquired over 30 years of international experience in the Biosciences, Healthcare and Financial industries. Notably, Mr. Bellido managed a CAD 300M life science investment Fund (SGF-Santé) that produced several key players in the Medical Device industry.